Author:
Chen Qiang,Wang Lu,Li Sirong,Lv Dan,Li Xinyi,Yin Wenting,Hu Ting,Li Conghu,Cheng Xu
Reference43 articles.
1. A comprehensive review;Carbohydr. Polym,2021
2. Chitosan oligosaccharide: Biological activities and potential therapeutic applications;C Muanprasat;Pharmacol. Therapeut,2017
3. Chitosan ol-igosaccharide attenuates nonalcoholic fatty liver disease induced by high f at diet through reducing lipid accumulation, inflammation and oxidative stre ss in C57BL/6 mice;W Tao;Mar. Drugs,2019
4. Mutual inte ra-ction between endoplasmic reticulum and mitochondria in nonalcoholic fat t-y liver disease;J Wang;Lipids Health Dis,2020
5. Chitosan and chitooligosaccharide: The promising non-plant-derived prebiotics with multiple biological activities;Z Guan;Int. J. Mol. Sci,2022